Details

NameSymbolSector
SHUKRA PHARMACEUTICALS LIMITEDSHUKRAPHARPharmaceuticals
Open
66.85
High
71.81
Low
66.85
Close
68.91
Volume
697206
Exchange
bse
Time
16-Oct-2026

Outlook

Score:  

4.75

Rating:  

FAIR

Candlestick Pattern

Candle pattern of Shukra Pharmaceuticals is  
None
Estimated Stoploss of Shukra Pharmaceuticals is ₹  
66.85
Shukra Pharmaceuticals has a  
Bullishℹ
 pattern. 
Formation of  
None
 candle pattern indicates the trend direction of Shukra Pharmaceuticals is  
Unpredictableℹ
. 

Trend

Shukra Pharmaceuticals is in  
Sideways trendℹ
. 
Price of Shukra Pharmaceuticals is  
Upℹ
 by  

31.91

%. 
Target
Buy @ 

18.5

Sell @ 

71.76

Current @ 

68.91

Volume

Shukra Pharmaceuticals has seen  
Moderateℹ
 volume of trades. 
Though the volume trend for Shukra Pharmaceuticals appears  
Bullishℹ
 the participants seem to be  
Weak Buyersℹ
The trade volume of Shukra Pharmaceuticals is  

Up

 by  

22.68

% 

Valuation

The current market price of Shukra Pharmaceuticals is  
Overvaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 86cr and total assets worth ₹ 86cr, the balance sheet of Shukra Pharmaceuticals is:  
Balancedℹ
. 
Cashflow
Shukra Pharmaceuticals has  
Maintainedℹ
 cash flow because there is  

Surplus

 of  

₹ 2cr

. It is  
Downℹ
 by  

66.67

%. 

(*Mar 2025)

58.33% i.e. ₹ 7cr earned in operatingℹ
8.33% i.e. ₹ 1cr spent in investingℹ
33.33% i.e. ₹ 4cr spent in financingℹ
0% in otherℹ
Shukra Pharmaceuticals has  
Excellentℹ
 cash flow because there is  

Surplus

 of  

₹ 6cr

. It is  
Upℹ
 by  

100

%. 

(*Mar 2024)

27.78% i.e. ₹ 5cr spent in operatingℹ
5.56% i.e. ₹ 1cr spent in investingℹ
66.67% i.e. ₹ 12cr earned in financingℹ
0% in otherℹ
Income
The income of Shukra Pharmaceuticals is  

₹ 7cr

 and  

Profit

 is :  

₹ 2cr

(*Sep 2025)

Shukra Pharmaceuticals Profit is up by:  

100

% and Income is Up by:  

16.67

% 

(*Sep 2025)

The income of Shukra Pharmaceuticals is  

₹ 6cr

 and  

Profit

 is :  

₹ 1cr

(*Jun 2025)

Shukra Pharmaceuticals Profit is down by:  

80

% and Income is Down by:  

57.14

% 

(*Jun 2025)

The income of Shukra Pharmaceuticals is  

₹ 14cr

 and  

Profit

 is :  

₹ 5cr

(*Mar 2025)

Shukra Pharmaceuticals Profit is up by:  

66.67

% and Income is Up by:  

27.27

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.